This is the 2026 BioTech Nation "5":
Five Companies Ready to Make a Difference.
We're highlighting 5 biotech companies with a special release of interviews in time for the 44th Annual J.P. Morgan Healthcare Conference right here in San Francisco.
Hear all 5 interviews at https://www.biotechnation.com/jpm-2026-btn-5

On this episode of BioTech Nation...
Ever wonder what makes opioids so addictive? Moira speaks with Ketan Mehta, Founder and CEO of Tris Pharma, about opioid-induced euphoria...and an opioid that's actually meant to suppress this response. 

For more information about BioTech Nation and the companies featured here, visit: TechNation.com